ON ON Delivers Q1 2026 Beat EPS 064 vs 062 Expected TScan Therapeutics TCRX Q1 2026 Miss What Went Wrong Forward FWRD Q1 2026 Results Fall Short EPS 045 Revenue NA Nuveen NXP Flat at 1410 Consolidation Continues 20260520 Heartbeam BEAT Climbs 406 Resistance at 099 in Focus 20260520 Cellebrite CLBT Reports Strong Q1 2026 Revenue NA EPS Beats Taiwan Arms Sales Emerge as Flashpoint in TrumpXi Talks Shaping Geopolitical Risk for Markets